Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

India flag India · Delayed Price · Currency is INR
83.43
-0.05 (-0.06%)
At close: Jun 19, 2026
Market Cap2.37B +56.1%
Revenue (ttm)4.72B -0.4%
Net Income39.68M -1.4%
EPS1.39 -2.1%
Shares Out 28.45M
PE Ratio60.02
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,323
Open81.81
Previous Close83.48
Day's Range79.51 - 85.00
52-Week Range50.40 - 100.00
Beta1.14
AnalystsStrong Buy
Price Targetn/a
Earnings DateMay 29, 2026

About BOM:524412

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1990
Employees 132
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524412
Full Company Profile

Financial Performance

In fiscal year 2026, BOM:524412's revenue was 4.72 billion, a decrease of -0.35% compared to the previous year's 4.74 billion. Earnings were 39.68 million, a decrease of -1.40%.

Financial Statements